A BILL 
To amend title XXVII of the Public Health Service Act 
to prohibit group health plans and health insurance 
issuers offering group or individual health insurance cov-
erage from imposing cost-sharing requirements or treat-
ment limitations with respect to diagnostic examinations 
for breast cancer that are less favorable than such re-
quirements with respect to screening examinations for 
breast cancer. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
01:38 May 04, 2019
H2428
2 
•HR 2428 IH
SECTION 1. SHORT TITLE. 
1
This Act may be cited as the ‘‘Access to Breast Can-
2
cer Diagnosis Act of 2019’’. 
3
SEC. 2. REQUIRING PARITY IN COST-SHARING AND TREAT-
4
MENT LIMITATIONS WITH RESPECT TO DIAG-
5
NOSTIC AND SCREENING EXAMINATIONS FOR 
6
BREAST CANCER. 
7
(a) IN GENERAL.—Section 2719A of the Public 
8
Health Service Act (42 U.S.C. 300gg–19a) is amended by 
9
adding at the end the following new subsection: 
10
‘‘(e) DIAGNOSTIC AND SCREENING EXAMINATIONS 
11
FOR BREAST CANCER PARITY.— 
12
‘‘(1) IN
GENERAL.—In the case of a group 
13
health plan, or a health insurance issuer offering 
14
group or individual health insurance coverage, that 
15
provides benefits with respect to a diagnostic exam-
16
ination for breast cancer furnished to an individual 
17
enrolled under such plan or such coverage, such plan 
18
or such coverage shall ensure that— 
19
‘‘(A) the cost-sharing requirements appli-
20
cable to such examination for such individual 
21
are no less favorable than such requirements 
22
applicable to a screening examination for breast 
23
cancer for such individual; and 
24
‘‘(B) the treatment limitations applicable 
25
to such diagnostic examination for breast can-
26
01:38 May 04, 2019
H2428
3 
•HR 2428 IH
cer for such individual are no less favorable 
1
than such limitations applicable to a screening 
2
examinations for breast cancer for such indi-
3
vidual. 
4
‘‘(2) RESTRICTION ON CERTAIN CHANGES.—A 
5
group health plan or health insurance issuer may 
6
not, for the sole purpose of complying with para-
7
graph (1), increase cost-sharing requirements with 
8
respect to screening examinations for breast cancer. 
9
‘‘(3) CONSTRUCTION.—Nothing in this sub-
10
section shall be construed— 
11
‘‘(A) to require the use of diagnostic ex-
12
aminations for breast cancer as a replacement 
13
for screening examinations for breast cancer; 
14
‘‘(B) to prohibit a group health plan or 
15
health insurance issuers from requiring prior 
16
authorization or imposing other appropriate uti-
17
lization controls in approving coverage for any 
18
screening or diagnostic imaging; or 
19
‘‘(C) to supersede a State law that pro-
20
vides greater protections with respect to the 
21
coverage of diagnostic examinations for breast 
22
cancer than is provided under this subsection. 
23
‘‘(4) DEFINITIONS.—In this subsection: 
24
01:38 May 04, 2019
H2428
4 
•HR 2428 IH
‘‘(A) COST-SHARING REQUIREMENT.—The 
1
term ‘cost-sharing requirement’ includes a de-
2
ductible, coinsurance, copayment, and any max-
3
imum limitation on the application of such a 
4
deductible, coinsurance, copayment, or similar 
5
out-of-pocket expense. 
6
‘‘(B) 
DIAGNOSTIC
EXAMINATION
FOR 
7
BREAST CANCER.—The term ‘diagnostic exam-
8
ination for breast cancer’ means a medically 
9
necessary and appropriate (as determined by 
10
the health care professional treating the indi-
11
vidual) examination for breast cancer to evalu-
12
ate an abnormality in the breast that is— 
13
‘‘(i) seen or suspected from a screen-
14
ing examination for breast cancer; 
15
‘‘(ii) detected by another means of ex-
16
amination; or 
17
‘‘(iii) suspected based on the medical 
18
history or family medical history of the in-
19
dividual. 
20
‘‘(C) EXAMINATION
FOR
BREAST
CAN-
21
CER.—The term ‘examination for breast cancer’ 
22
includes such an examination using breast 
23
ultrasound, breast magnetic resonance imaging, 
24
or mammography. 
25
01:38 May 04, 2019
H2428
5 
•HR 2428 IH
‘‘(D) TREATMENT LIMITATION.—The term 
1
‘treatment limitation’ includes limits on the fre-
2
quency of treatment, number of visits, days of 
3
coverage, or other similar limits on the scope or 
4
duration of treatment.’’. 
5
(b) APPLICATION
TO GRANDFATHERED HEALTH 
6
PLANS.—Section 1251(a)(4)(A) of the Patient Protection 
7
and Affordable Care Act (42 U.S.C. 18011(a)(4)(A)) is 
8
amended— 
9
(1) by striking ‘‘title’’ and inserting ‘‘title, or as 
10
added after the date of the enactment of this Act)’’; 
11
and 
12
(2) by adding at the end the following new 
13
clause: 
14
‘‘(v) Section 2719A(e) (relating to 
15
parity for diagnostic and screening exami-
16
nations for breast cancer).’’. 
17
(c) EFFECTIVE DATE.—The amendments made by 
18
this section shall apply with respect to plan years begin-
19
ning on or after January 1, 2020. 
20
Æ 
01:38 May 04, 2019
H2428
